Response Rates to Medical Treatments and Long-term Clinical Outcomes of Nonsurgical Patients With Intestinal Behçet Disease

Journal of Clinical Gastroenterology

Volumn 44, Issue 6, 2010, Pages e116-e122

  Chung, Moon Jae ^a   Cheon, Jae Hee ^a   Kim, Seung Up ^b   Park, Jae Jun ^b   Kim, Tae Il ^b   Kim, Nam Kyu ^b   Kim, Won Ho ^b  

^a Departments of Internal Medicine and Institute of Gastroenterology   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Intestinal Beh et disease; Prognosis; Recurrence; Surgery

Indexed keywords

AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; BEHCET SYNDROME; DRUG COMBINATION; FEMALE; HUMAN; INTESTINAL DISEASES; KOREA; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; TIME; TREATMENT OUTCOME; ULCER; YOUNG ADULT; ARTICLE; BEHCET DISEASE; GASTROINTESTINAL SYMPTOM; INTESTINE ULCER; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELAPSE; REMISSION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; BEHCET SYNDROME; COLCHICINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL DISEASES; KOREA; MALE; MESALAMINE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; ULCER; YOUNG ADULT;

EID: 77953800537     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181c8a50f     Document Type: Article

References (29)

1. Kobayashi K, Ueno F, Bito S, et al. Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach. J Gastroenterol. 2007;42:737-745.
2. Sakane T, Takeno M, Suzuki N, et al. Behçet's disease. N Engl J Med. 1999;341:1284-1291.
3. Shimizu T, Ehrlich GE, Inaba G, et al. Behçet disease (Behçet syndrome). Semin Arthritis Rheum. 1979;8:223-260.
4. Oshima Y, Shimizu T, Yokohari R, et al. Clinical studies on Behçet's syndrome. Ann Rheum Dis. 1963;22:36-45.
5. Ebert EC. Gastrointestinal manifestations of Behçet's Disease. Dig Dis Sci. 2008;54:201-207.
6. Kitauchi S, Nishi S, Nishioka S. Intestinal Behçet's disease: epidemiology, pathophysiology and potential of mesalazine. BioDrugs. 2000;13:409-413.
7. Lee CK, Kim HJ. Pathogenesis and treatment of intestinal Behçet's disease. Korean J Gastroenterol. 2007;50:3-8.
8. Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behcet's disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2008;67:1656-1662.
9. Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet's disease. J Clin Gastroenterol. 2000;30:144-154.
10. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990;335:1078-1080.
11. Mizushima Y, Inaba G, Mimura Y, et al. Diagnostic criteria for Behçet's disease in 1987, and guidelines for treating Behçet's disease. Saishin-Igaku. 1987;43:382-391.
12. Lee CR, Kim WH, Cho YS, et al. Colonoscopic findings in intestinal Behçet's disease. Inflamm Bowel Dis. 2001;7:243-249.
13. Jung HC, Rhee PL, Song IS, et al. Temporal changes in the clinical type or diagnosis of Behçet's colitis in patients with aphthoid or punched-out colonic ulcerations. J Korean Med Sci. 1991;6:313-318.
14. Chung YJ, Park YD, Kim SG, et al. Comparison of the clinical outcomes between intestinal Behcet's disease and simple ulcer. Korean J Med. 2007;73:575-586.
15. Kim JS, Lim SH, Choi IJ, et al. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Endoscopy. 2000;32:635-640.
16. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43(10 suppl):S85-S93.
17. Cheon JH, Kim WH. Recent advances of endoscopy in inflammatory bowel disease. Gut Liver. 2007;1:118-125.
18. Hur H, Min BS, Kim JS, et al. Patterns of recurrence and prognosis in patients with intestinal Behçet's disease who underwent a bowel resection. J Korean Soc Coloproctol. 2008;24:166-174.
19. Choi IJ, Kim JS, Cha SD, et al. Long-term clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum. 2000;43:692-700.
20. Naganuma M, Iwao Y, Inoue N, et al. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease. Am J Gastroenterol. 2000;95:2848-2851.
21. Byeon JS, Choi EK, Heo NY, et al. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case. Dis Colon Rectum. 2007;50:672-676.
22. Kram MT, May LD, Goodman S, et al. Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case. Dis Colon Rectum. 2003;46:118-121.
23. Hassard PV, Binder SW, Nelson V, et al. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report. Gastroenterology. 2001;120:995-999.
24. Travis SP, Czajkowski M, McGovern DP, et al. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut. 2001;49:725-728.
25. Mussack T, Landauer N, Ladurner R, et al. Successful treatment of cervical esophageal perforation in Behcet's disease with drainage operation and infliximab. Am J Gastroenterol. 2003;98:703-704.
26. Naganuma M, Sakuraba A, Hisamatsu T, et al. Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease. Inflamm Bowel Dis. 2008;14:1259-1264.
27. Lee JH, Kim TN, Choi ST, et al. Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab). Korean J Intern Med. 2007;22:24-27.
28. Ju JH, Kwok SK, Seo SH, et al. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab. Clin Rheumatol. 2007;26:1383-1385.
29. Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104:2492-2499.